The COVID-19 pandemic may be over, but our immune systems are still feeling the impact. After years of battling constant viral threats, from COVID-19 to seasonal flu and other infections, our body’s defense system is exhausted. Many people continue to experience lingering inflammation, frequent illnesses, and slower recovery times. This extended state of immune stress has compromised us further to chronic illness, including autoimmune diseases and even neurodegenerative diseases such as Parkinson's. So why is our immune system still in trouble? And how do we give it its power back? Understanding immune exhaustion is the beginning of rebuilding our body's natural immunity.

A weakened immune system makes people more susceptible to disease, mental illnesses, and even sleep disorders. Now, new research indicates that immune system depletion may play an important role in the onset of Parkinson's disease, a degenerative neurologic disorder that compromises movement and cognition.

Role of Inflammation in Parkinson's Disease

Dysfunctional immune response is a leading cause of long-standing inflammation within the body, that has been found to contribute towards a multitude of conditions, including cardiovascular conditions, diabetes, depression, and neurodegenerative diseases such as Alzheimer's.

As people age, their immune system naturally becomes less effective. This deterioration, referred to as immune exhaustion, may be a key contributor to the onset and progression of Parkinson’s disease. Rebecca Wallings, a Parkinson’s Foundation Launch Award grant recipient and senior postdoctoral fellow at the University of Florida, believes that an accumulation of exhausted immune cells could be driving neurodegeneration in Parkinson’s patients.

How a Tired Immune System Might Affect Parkinson's?

Parkinson's disease is most commonly linked with the degeneration and loss of dopaminergic neurons—motor nerve cells that produce dopamine, an essential neurotransmitter for movement. While researchers have long suspected inflammation is involved in this neurodegeneration, the mechanisms are not yet well understood.

Wallings' study is on immune cell exhaustion, a process by which aging immune cells fail to control immune responses effectively. Her research indicates that instead of dampening inflammation in Parkinson's patients, attempts should be made to rejuvenate the immune system to regain its functionality.

Energy Deficiency in Immune Cells

One of the major findings of Wallings' work is the function of mitochondrial impairment in immune cell exhaustion. Mitochondria are commonly called the powerhouses of cells, as they are vital for generating energy. As mitochondria age and become inefficient, immune cells fail to function well, potentially accelerating neurodegeneration in Parkinson's disease.

Wallings has found that mutations in the LRRK2 gene, a recognized genetic risk factor for Parkinson's disease, are linked with defective mitochondrial function and immune cell exhaustion. Her current work includes testing various therapeutic approaches to restore mitochondrial function in immune cells with the potential to enhance the immune system and potentially prevent or treat Parkinson's disease.

Will Rejuvenating the Immune System Help in Treatment?

For decades, the standard practice in treating Parkinson's has been to suppress brain inflammation. Yet Wallings' work indicates that instead of slowing down immune responses, restoring the immune system could be a more successful strategy. By addressing mitochondrial impairment and immune resilience, researchers can potentially reverse or slow down Parkinson's disease.

Wallings is now looking into how to rejuvenate immune cells by fixing mitochondria. She studies immune cells from patients with Parkinson's as well as from healthy subjects and performs experiments on animal models to determine if rejuvenation of the immune system could result in improved disease outcomes.

Lifestyle Factors That May Affect Parkinson's Risk

While there is no cure for Parkinson's disease, some lifestyle adjustments may decrease the chances of developing the illness. Since neurodegenerative diseases are associated with chronic inflammation and immune dysfunction, developing habits that enhance immune function might prove helpful.

Diet: There is evidence to suggest that eating in accordance with the Mediterranean or MIND diets, both high in antioxidants, healthy fats, and anti-inflammatory foods, can encourage brain wellness and reduce Parkinson's risk.

Avoiding Dangerous Substances: Restricting alcohol and nicotine use can maintain a robust immune system and suppress inflammation.

Reducing Stress: Chronic stress weakens immune function, so methods such as meditation, exercise, and sufficient sleep can lead to improved overall well-being.

Every year on October 2, World No Alcohol Day urges people to pause and think about alcohol's place in everyday life. Here's where the day came from, and what current research actually shows about drinking.

World No Alcohol Day: Origins

It began in 2008, when India's then Union Health Minister, Dr. Anbumani Ramadoss, proposed a global alcohol-free day at the World Health Assembly in Geneva, according to National Day Calendar. The proposal drew support from 11 Southeast Asian countries.

The World Health Organization never formally adopted October 2 as an official global observance, according to a summary on Checkiday. There are, in fact, three dates tied to alcohol awareness worldwide: October 2 and October 3, observed by many groups as World Alcohol-Free Day or World Temperance Day, and November 15.

In India, October 2 is also a nationwide dry day, with no alcohol sales permitted, and is marked separately as National Anti-Drug Addiction Day.

Also Read: Does Experimental Obesity Drug Petrelintide Cause Fewer GI Side Effects Than Ozempic? Lancet Study Shows Promise

What Science Says About Alcohol Now

The science has shifted since 2008. In January 2023, the World Health Organization stated plainly that no level of alcohol consumption is safe for health, publishing the position in The Lancet Public Health. The WHO said current evidence cannot identify any threshold below which alcohol's cancer-causing effects switch off.

Alcohol is classified as a Group 1 carcinogen, the same risk category as tobacco and asbestos, and is linked to at least seven types of cancer, including the most common cancers in men and women, bowel and breast cancer, according to the WHO.

Globally, alcohol was responsible for an estimated 741,300 new cancer cases and contributed to nearly 400,000 cancer deaths in a single year, as per Lancet-based estimates cited by the Union for International Cancer Control.

Previous research has showed some benefits of wine, but the majority scientific consensus now is that there is no safe levels of alcohol. The World Health Organization says health risks begin with the first drop of alcohol, meaning no level of consumption is completely safe or risk-free.

The toll beyond cancer

Cancer isn't the only risk. Alcohol use is tied to roughly 2.5 million deaths worldwide each year, including 320,000 among people aged 15 to 29, according to the WHO. Beyond individual health, alcohol-related harm also means more road accidents, violence, and strain on healthcare systems.

A May 2026 study linked alcohol to 62 disorders, ranging from heart and digestive diseases to mental and neurological conditions and cancers.

The study, published in the journal Addiction, showed that the fully alcohol-attributable conditions are mainly grouped under non-communicable diseases and injuries.

These include:

• Endocrine, nutritional, and metabolic diseases
• Mental and behavioral disorders
• Diseases of the nervous system
• Diseases of the circulatory system, such as alcoholic cardiomyopathy
• Digestive diseases
• Alcoholic liver disease and cirrhosis.

The data also included psychotic disorders, gastritis, ulcers, pancreatitis, fatty liver disease, pregnancy- and perinatal-related conditions such as fetal alcohol syndrome and fetal alcohol spectrum disorders, as well as external causes and injuries, including alcohol poisoning.

Excessive alcohol consumption is one of the leading preventable causes of illness and death in the US, according to the Centers for Disease Control and Prevention.

Research shows that alcohol accounts for approximately half of all liver-related deaths, while alcohol-associated cirrhosis has become the leading cause of liver transplants.

Actress Amanda Peet has opened up about her breast cancer diagnosis, revealing a “weird” change in the skin that did not feel like the typical lump many people associate with breast cancer.

A breast lump is a well-known warning sign of breast cancer, but the disease can also cause changes in the breast’s skin, shape or texture. This makes it important to pay attention to changes that may not feel like a distinct lump.

What Did Amanda Peet Feel?

Peet, 54, recalled noticing something unusual while getting dressed.

“I was in my closet, I was probably putting something on and I felt a weird — it just didn’t feel like normal skin, but it wasn’t the frozen pea that everybody talks about,” she told Today.com.

Peet described the sensation as a change in how the skin felt rather than a clearly defined lump.

Other breast cancer warning signs can include changes in breast size or shape, skin dimpling, swelling, redness, nipple changes or unusual discharge. Skin that becomes pitted and resembles an orange peel, known as peau d’orange, can also be a warning sign.

Importantly, breast cancer can sometimes be present without an obvious lump.

Peet had been undergoing regular breast screening and follow-up because of her breast health history. She has said that an MRI did not show the cancer, but a subsequent ultrasound detected an abnormality. A biopsy later confirmed a tumor.

She was diagnosed with hormone-receptor-positive, HER2-negative invasive lobular carcinoma and underwent a lumpectomy followed by radiation.

What Is Invasive Lobular Carcinoma?

Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer and accounts for about 10% of invasive breast cancers.

Unlike many breast cancers that form a distinct lump, ILC can grow in a more diffuse pattern. It may cause thickening, fullness or a subtle change in the breast rather than a clearly defined mass.

Because of the way ILC grows, it can sometimes be harder to detect on mammography. Additional imaging, including ultrasound or MRI, may be used depending on an individual's symptoms, breast density and clinical assessment.

Most invasive lobular cancers are hormone-receptor positive. Peet wrote that she had been seeing a breast surgeon every six months for checkups. Her cancer was diagnosed at Stage 1.

“I think about how lucky I was in so many ways,” she said.

Why Early Detection Matters

Breast cancer screening is designed to detect cancer before signs or symptoms become apparent. The goal is early detection, when treatment may be more effective.

The appropriate screening schedule depends on age, breast cancer risk, family history and other factors. In the US, the US Preventive Services Task Force recommends that women at average risk aged 40 to 74 have a mammogram every two years.

People with a higher risk of breast cancer may need a different screening approach or additional imaging. Discussing individual risk and screening options with a healthcare professional can help determine what is appropriate.

October Is Breast Cancer Awareness Month

October marks Breast Cancer Awareness Month, with this year’s theme, “Every story is unique, every journey matters,” highlighting that every breast cancer experience is different.

According to the World Health Organization (WHO), breast cancer is the most common cancer among women. About 80% of breast cancers occur in women with no specific risk factors other than sex and age.

In 2024:

• 2.4 million women were diagnosed with breast cancer worldwide.
• 694,000 women died from the disease.
• 8.2 million women were living with breast cancer at the end of the year.

After eliminating measles in 2000, the US is now seeing a sharp increase in cases, with 3,659 confirmed cases reported as of September 24, 2026. Pennsylvania has reported five measles-related deaths this year, the first such deaths in the state in 35 years.

The number has risen significantly from previous years. The US reported 2,289 cases in 2025, compared with 285 in 2024 and just 85 cases in 2000.

Measles can cause serious complications, including pneumonia and encephalitis, or brain swelling, and can be fatal.

Two doses of the measles, mumps and rubella (MMR) vaccine can prevent measles by up to 97%, although breakthrough infections can still occur.

Around 95% of reported cases have been among unvaccinated people, although breakthrough infections have also been reported among people who were fully vaccinated. However, measles is not expected to be as severe in people who are vaccinated.

“Their illness will be much more mild and less likely to cause serious illness than if they had not received two vaccines,” Dr. Pia Fenimore, chief and vice chair of pediatrics at Penn Medicine Lancaster General Health.

Yet according to experts some people can take a booster shot to stay safe.

Who May Need a Measles Booster?

The first measles vaccine was introduced in the US in 1963, but the formulation used between 1963 and 1967 was less effective than current versions.

Adults vaccinated during that period may need another dose if they have not received a later measles vaccine.

People born before 1957 are generally considered to have presumptive evidence of immunity because measles circulated widely before routine vaccination, and most people in this age group were naturally infected.

Some people may need individualized vaccination guidance rather than standard recommendations, including:

• People with uncertain vaccination status or no vaccination records
• People who received an inactivated measles vaccine between 1963 and 1967
• People with a weakened immune system
• Pregnant people

A measles vaccine booster may also be considered for children who received only one MMR dose, high-risk adults such as healthcare workers or international travelers, and people whose testing shows they lack immunity.

Can A Blood Test Check Measles Immunity?

In cases where people do not remember or have no records of two-dose measles vaccination, an Immunoglobulin G (IgG) antibody test can help assess whether they have antibodies against measles.

If testing shows sufficient measles IgG antibodies, the person is considered immune. If immunity is not established, vaccination may be recommended based on their individual circumstances.

Why Adults Also Need To Be Alert

Measles is often associated with children, but adults can also become infected.

“We often forget about adults getting measles ... 38% to 40% of cases this year of measles have been in adults. Adults become infected at the same, if not higher, rates than children themselves ... in 2025, just over half of the measles hospitalizations were actually ... adults,” Dr. Gavin Harris, an infectious diseases physician with Emory Healthcare in Georgia and the associate medical director of the Serious Communicable Diseases Unit.

What If You Were Exposed To Measles?

Measles is highly contagious and can spread through even limited exposure to the virus. With the virus outbreak, it is likely for people to get exposed to it.

The measles vaccine remains the absolute best way to prevent disease.

A shot within three days of exposure to the contagious virus can help prevent the disease. Intravenous immunoglobulin (IVIG) given within six days can also provide protection after exposure.